Viva Biotech
(OTC) VBIZF
Viva Biotech Financials at a Glance
Market Cap
$724.95M
Revenue (TTM)
$3.70B
Net Income (TTM)
$385.43M
EPS (TTM)
$0.02
P/E Ratio
15.33
Dividend
$0.00
Beta (Volatility)
-6.44 (Low)
Dividend
$0.00
Beta (Volatility)
-6.44 (Low)
Price
$0.34
Volume
410
Open
$0.34
Price
$0.34
Volume
410
Open
$0.34
Previous Close
$0.34
Daily Range
$0.34 - $0.34
52-Week Range
$0.18 - $0.43
Dividend
$0.00
Beta (Volatility)
-6.44 (Low)
Price
$0.34
Volume
410
Open
$0.34
Previous Close
$0.34
Daily Range
$0.34 - $0.34
52-Week Range
$0.18 - $0.43
VBIZF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Viva Biotech
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
2,169
CEO
Chen Mao
Website
www.vivabiotech.comHeadquarters
Shanghai, 201318, CN
VBIZF Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
11%
Net Income Margin
13%
Return on Equity
6%
Return on Capital
3%
Return on Assets
3%
Earnings Yield
6.52%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$724.95M
Shares Outstanding
2.11B
Volume
410
Short Interest
0.00%
Avg. Volume
1.65K
Financials (TTM)
Gross Profit
$638.64M
Operating Income
$188.26M
EBITDA
$393.87M
Operating Cash Flow
$373.99M
Capital Expenditure
$191.67M
Free Cash Flow
$182.32M
Cash & ST Invst.
$1.13B
Total Debt
$1.33B
Viva Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$882.67M
-12.9%
Gross Profit
$310.88M
-6.5%
Gross Margin
35.22%
N/A
Market Cap
$724.95M
N/A
Market Cap/Employee
$351.41K
N/A
Employees
2,063
N/A
Net Income
$96.33M
+182.2%
EBITDA
$178.05M
+9.3%
Quarterly Fundamentals
Net Cash
$199.29M
+77.0%
Accounts Receivable
$630.06M
+54.7%
Inventory
$335.91M
+29.3%
Long Term Debt
$358.42M
-62.3%
Short Term Debt
$972.83M
+2.1%
Return on Assets
3.03%
N/A
Return on Invested Capital
3.32%
N/A
Free Cash Flow
$55.00M
-74.5%
Operating Cash Flow
$129.82M
-59.1%